The Pharmacy Times® Diabetes Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of chronic diseases that result in high blood glucose.
September 15th 2025
GLP-1 receptor agonists enhance glycemic control and weight management in youth with type 2 diabetes (T2D) and obesity, while safety concerns persist.
Combined Insulin Degludec and Aspart in Insulin-Naïve Patients
October 27th 2016Patients with type 2 diabetes eventually need insulin therapy as their disease progresses. The American Diabetes Association recommends basal-only therapy initially, with the addition of bolus meal-time insulin as needed. However, recent research supports starting patients on combined basal-bolus regimens to control blood sugar regardless of added hypoglycemia risk.
Read More
Simple Chart Explains Medications for Diabetes Treatment
October 26th 2016For decades, clinicians relied on a limited number of drugs, including sulfonylureas and metformin, to help patients with type 2 diabetes. However, in the past 20 years, an increasing number of glucose-lowering drugs for diabetes treatment have become available.
Read More
Medicare Part D Insulin Tiering Change: Impact on Health Outcomes
This study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
Read More